Krishna Institu.

Why is Krishna Institute of Medical Sciences Ltd falling/rising?

As of 28-Aug, the stock price of Krishna Institute of Medical Sciences Ltd is slightly declining at Rs 769.80, reflecting a 1-week drop of 1.54% and a 1-month drop of 3.46%. Despite a year-to-date increase of 26.80%, the company faces challenges with a 31.23% drop in net profit and poor long-term growth prospects, leading to negative investor sentiment.

As of 28-Aug, the stock price of Krishna Institute of Medical Sciences Ltd is experiencing a slight decline, currently at Rs 769.80, down by 0.05 (-0.01%). This minor decrease is reflective of the stock's performance over the past week and month, where it has underperformed compared to the benchmark Sensex, with a 1-week decline of 1.54% and a 1-month decline of 3.46%. <BR><BR>Despite a year-to-date increase of 26.80%, the company has faced significant challenges, including a notable drop in net profit by 31.23% and negative results for the last five consecutive quarters. The operating profit has only grown at an annual rate of 4.18% over the last five years, indicating poor long-term growth prospects. Additionally, the company's profitability metrics, such as the operating profit to interest ratio, are at their lowest, further contributing to concerns about its financial health.<BR><BR>While there are positive factors, such as high management efficiency and strong institutional holdings, these have not been sufficient to offset the negative sentiment stemming from the company's declining profits and poor quarterly results. The stock's performance today has also been characterized by underperformance against its sector, which may further influence investor sentiment negatively. Overall, the combination of declining profits, poor long-term growth, and recent negative results are key factors contributing to the stock's current downward movement.

Which are the latest news on Krishna Institu.?

Should I buy, sell or hold Krishna Institute of Medical Sciences Ltd?

Who are in the management team of Krishna Institu.?

The management team of Krishna Institu includes Bhaskara Rao Bollineni (Chairman & Managing Director), Abhinay Bollineni (Executive Director & CEO), Dandamudi Anitha (Whole Time Director), and several independent and non-executive directors. They oversee the company's strategic direction and operations.

The management team of Krishna Institu includes the following individuals:<BR><BR>1. **Bhaskara Rao Bollineni** - Chairman & Managing Director<BR>2. **Abhinay Bollineni** - Executive Director & CEO<BR>3. **Dandamudi Anitha** - Whole Time Director & Executive Director<BR>4. **Rajeswara Rao Gandu** - Independent Director<BR>5. **Saumen Chakraborty** - Independent Director<BR>6. **Pankaj Vaish** - Independent Director<BR>7. **Ratna Kishore Kaza** - Independent Director<BR>8. **J V Ramudu** - Independent Director<BR>9. **Y Prameela Rani** - Independent Director<BR>10. **Shantanu Rastogi** - Non-Executive Director<BR>11. **Adwik Bollineni** - Additional Director<BR><BR>This team is responsible for guiding the company's strategic direction and operations.

What does Krishna Institu. do?

Krishna Institute of Medical Sciences Ltd is a small-cap company in the hospital industry, incorporated in 1973, with recent net sales of ₹1,180 Cr and a net profit of ₹42 Cr as of June 2026. It has a market cap of ₹33,821 Cr, a P/E ratio of 160, and a debt-equity ratio of 1.85.

Overview:<BR>Krishna Institute of Medical Sciences Ltd operates in the hospital industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in 1973 as 'Jagjit Singh and Sons Private Limited' and later changed its name to 'Krishna Institute of Medical Sciences Private Limited' in 2004. Upon converting to a public company, it adopted its current name on January 29, 2004. The latest quarterly results report net sales and profit for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1,180 Cr (Quarterly Results - Jun 2026)<BR>Most recent Net Profit: 42 Cr (Quarterly Results - Jun 2026)<BR>Market-cap value: INR 33,821 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 160.00<BR>Industry P/E: 67<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 1.85<BR>Return on Equity: 11.03%<BR>Price to Book: 14.98<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

Who are the peers of the Krishna Institu.?

Peers of Krishna Institu. include Aster DM Quality, Fortis Health, Global Health, Narayana Hrudaya, Dr Agarwal's Health, Rainbow Children, Health.Global, and Jupiter Life Line. Krishna Institu. has a 1-year return of 10.35%, which is higher than Fortis Health's -4.49% but lower than Aster DM Quality's 34.49%.

Peers: The peers of Krishna Institu. are Aster DM Quality, Fortis Health., Global Health, Narayana Hrudaya, Dr Agarwal's Hea, Rainbow Child., Health.Global, and Jupiter Life Lin.<BR><BR>Quality Snapshot: Excellent management risk is observed at Aster DM Quality, Global Health, Narayana Hrudaya, Rainbow Child., and Jupiter Life Lin, while Average management risk is found at Fortis Health., Dr Agarwal's Hea, and Health.Global. Good growth is seen at Fortis Health., Narayana Hrudaya, Dr Agarwal's Hea, and Health.Global, while Below Average growth is noted for Aster DM Quality, Krishna Institu., Rainbow Child., and Jupiter Life Lin. Average capital structure is present at Aster DM Quality and Fortis Health., while Good capital structure is noted for Global Health, Narayana Hrudaya, Krishna Institu., Dr Agarwal's Hea, Rainbow Child., and Jupiter Life Lin, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aster DM Quality at 34.49%, while the lowest is Fortis Health. at -4.49%. Krishna Institu.'s 1-year return is 10.35%, which is higher than Fortis Health. but lower than Aster DM Quality. Additionally, Narayana Hrudaya and Fortis Health. have negative six-month returns.

How big is Krishna Institu.?

As of 14th August, Krishna Institute of Medical Sciences Ltd has a market capitalization of 34,016.33 Cr, with recent net sales of 4,212.50 Cr and a net profit of 204.30 Cr over the last four quarters.

As of 14th August, <BR><BR>Market Cap: Krishna Institute of Medical Sciences Ltd has a market capitalization of 34,016.33 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 4,212.50 Cr, while the sum of Net Profit for the same period is 204.30 Cr.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2026, with Shareholder's Funds amounting to 2,247.40 Cr and Total Assets totaling 7,631.30 Cr.

Are Krishna Institute of Medical Sciences Ltd latest results good or bad?

Krishna Institute of Medical Sciences Ltd's latest results show strong revenue growth of 35.33% year-on-year, reaching ₹1,179.50 crores, but net profit fell 47.20% to ₹41.50 crores, raising concerns about profitability and increased debt levels. Overall, while revenue growth is positive, the decline in profit and rising financial risk suggest mixed results.

The latest results for Krishna Institute of Medical Sciences Ltd present a mixed picture. On one hand, the company achieved impressive revenue growth, with net sales increasing by 35.33% year-on-year to ₹1,179.50 crores, marking the highest quarterly revenue in its history. This growth indicates strong demand and operational momentum across its hospital network.<BR><BR>However, the profitability metrics have raised concerns. The net profit for the quarter fell significantly by 47.20% year-on-year to ₹41.50 crores, and the operating margin contracted to 18.94%, down from 22.10% a year earlier. This margin compression is attributed to rising employee costs and increased interest expenses, which surged by 155.83% year-on-year. The company's debt levels have also escalated, leading to a debt-to-equity ratio of 1.89, indicating heightened financial risk.<BR><BR>Overall, while the revenue growth is a positive sign, the sharp decline in profitability and increased debt levels suggest that the results are not entirely favorable. Investors may need to weigh these factors carefully when considering the company's financial health and future prospects.

When is the next results date for Krishna Institute of Medical Sciences Ltd?

The next results date for Krishna Institute of Medical Sciences Ltd is 15 May 2026.

The next results date for Krishna Institute of Medical Sciences Ltd is scheduled for 15 May 2026.

Is Krishna Institu. technically bullish or bearish?

As of December 1, 2025, the trend is mildly bullish due to daily moving averages, but caution is advised as weekly MACD and KST are bearish, despite a bullish weekly RSI and mixed signals from Bollinger Bands.

As of 1 December 2025, the technical trend has changed from sideways to mildly bullish. The current stance is mildly bullish, driven by the daily moving averages indicating bullish momentum. However, the weekly MACD and KST are both mildly bearish, which suggests some caution. The weekly RSI is bullish, supporting the positive outlook, while the Bollinger Bands show a mixed signal with a bullish monthly perspective. Overall, the strength of the bullish sentiment is tempered by the bearish signals in the weekly indicators.

Is Krishna Institu. overvalued or undervalued?

As of November 26, 2025, Krishna Institute is considered very expensive with a PE ratio of 83.68, significantly higher than peers like Apollo Hospitals and Max Healthcare, indicating it is overvalued despite a 14.51% return over the past year compared to the Sensex's 7.01%.

As of 26 November 2025, the valuation grade for Krishna Institute has moved from expensive to very expensive. This indicates that the company is currently overvalued. Key ratios highlight this situation, with a PE ratio of 83.68, an EV to EBITDA of 38.97, and a Price to Book Value of 12.07. <BR><BR>In comparison to peers, Krishna Institute's valuation is notably higher than that of Apollo Hospitals, which has a PE ratio of 63.6 and an EV to EBITDA of 33.45, indicating that Krishna is trading at a significant premium. Additionally, Max Healthcare, another peer, has a PE ratio of 80.02, further emphasizing the elevated valuation of Krishna Institute. While the company has outperformed the Sensex over the past year with a return of 14.51% compared to the Sensex's 7.01%, the current valuation suggests caution for potential investors.

How has been the historical performance of Krishna Institu.?

Krishna Institu has demonstrated consistent growth from March 2020 to March 2025, with net sales increasing from INR 1,122.65 crore to INR 3,035.00 crore, and profit after tax rising from INR 115.07 crore to INR 414.50 crore. The company's total assets and cash flow from operating activities also significantly improved during this period.

Answer:<BR>The historical performance of Krishna Institu shows a consistent growth trajectory in net sales and profitability over the years.<BR><BR>Breakdown:<BR>Krishna Institu's net sales have increased significantly from INR 1,122.65 crore in March 2020 to INR 3,035.00 crore in March 2025, demonstrating a strong upward trend. The total operating income followed a similar pattern, reaching INR 3,035.00 crore in March 2025, up from INR 1,122.65 crore in March 2020. The company's operating profit (PBDIT) also saw substantial growth, rising from INR 251.08 crore in March 2020 to INR 814.60 crore in March 2025. Profit before tax increased from INR 140.53 crore in March 2020 to INR 557.90 crore in March 2025, while profit after tax rose from INR 115.07 crore to INR 414.50 crore in the same period. The company's total assets grew from INR 1,194.47 crore in March 2020 to INR 5,676.10 crore in March 2025, indicating a robust expansion in its asset base. Total liabilities also increased, from INR 1,194.47 crore to INR 5,676.10 crore, reflecting the company's growing financial commitments. Cash flow from operating activities improved from INR 201.00 crore in March 2020 to INR 581.00 crore in March 2025, while net cash inflow turned positive at INR 9.00 crore in March 2025, compared to a net outflow in previous years. Overall, Krishna Institu has shown strong growth in sales, profits, and asset accumulation over the past five years.

Who are the top shareholders of the Krishna Institu.?

The top shareholders of Krishna Institu include promoter Bhaskara Rao Bollineni with 26.27%, mutual funds at 25.35%, foreign institutional investors at 15.45%, and the SBI Small Cap Fund as the largest public shareholder with 6.31%. Individual investors collectively hold 11.24% of the shares.

The top shareholders of Krishna Institu include the promoters, who hold a majority stake in the company. The promoter with the highest holding is Bhaskara Rao Bollineni, with a significant 26.27%. Additionally, mutual funds hold 25.35% of the shares through 24 different schemes, while foreign institutional investors (FIIs) account for 15.45% with 171 FIIs involved. The highest public shareholder is the SBI Small Cap Fund, which holds 6.31%. Individual investors collectively hold 11.24% of the shares.

Has Krishna Institu. declared dividend?

No Dividend History Available